BUSINESSBLOOMBERG
Teva CEO on Drug Pipeline, Direct Listing on NYSE
Teva Pharmaceuticals CEO Richard Francis discussed the company's positive Q2 earnings, the impact of changing Medicare rules on patients, and the new direct listing on the NYSE with Bloomberg reporter Romaine Bostick.
Mentioned
Related Signal
Adjacent reporting
- Moderna CEO on Earnings, Flu Shots and Skin Cancer Trials
- Invesco CEO on Private Assets, QQQ Growth and Nasdaq Partnership
- Citi CFO Sees Trading Revenue Jump as CEO Fraser Drives Turnaround
- STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
- Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
- AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE